Key result
Advances in imaging, biomarkers, and RV function assessment guide prompt PAH diagnosis and management.
Why the study?
The diagnosis and assessment of pulmonary arterial hypertension are rapidly evolving with changes in disease definition, screening, diagnostic techniques, and follow-up assessment.
Answers are grounded in this paper and cite their sources.
Clinical review demonstrates advances in diagnostic criteria and right ventricular monitoring in pulmonary arterial hypertension, highlighting the necessity of early detection for emerging therapies.
The diagnosis and assessment of pulmonary arterial hypertension is a rapidly evolving area, with changes occurring in the definition of the disease, screening and diagnostic techniques, and staging and follow-up assessment. The definition of pulmonary hypertension has been simplified, and is now based on currently available evidence. There has been substantial progress in advancing the imaging techniques and biomarkers used to screen patients for the disease and to follow up their response to therapy. The importance of accurate assessment of right ventricular function in following up the clinical course and response to therapy is more fully appreciated. As new therapies are developed for pulmonary arterial hypertension, screening, prompt diagnosis, and accurate assessment of disease severity become increasingly important. A clear definition of pulmonary hypertension and the development of a rational approach to diagnostic assessment and follow-up using both conventional and new tools will be essential to deriving maximal benefit from our expanding therapeutic armamentarium.
No takes yet. Share an insight, caveat, or question.
Badesch et al. (2009) conducted a review in Pulmonary arterial hypertension. Advancements in imaging techniques, biomarkers, and right ventricular function assessment are essential for the prompt diagnosis and management of pulmonary arterial hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: